SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE H impact

Karyopharm Therapeutics Files for Bankruptcy, Plans Merger

Karyopharm Therapeutics filed for bankruptcy and plans to merge with Ayrmid Ltd. The company said it entered a restructuring support agreement with existing lenders and noteholders and plans to continue ordinary operations. Shares were recently down 84% to 11 cents.

KPTI

By Josh BeckermanKaryopharm Therapeutics filed for bankruptcy, planning to merge with Ayrmid Ltd. and to continue ordinary operations.Shares were recently down 84% to 11 cents.The cancer-focused drug company said it entered a restructuring support agreement with existing lenders and noteholders and…

Related stories